β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Franzén Stephanie) > β-cell adaptation i...

Fransson, Liselotte (författare)

β-cell adaptation in a mouse model of glucocorticoid-induced metabolic syndrome

Artikel/kapitelEngelska2013

Förlag, utgivningsår, omfång ...

Bioscientifica,2013
printrdacarrier

Nummerbeteckningar

LIBRIS-ID:oai:DiVA.org:uu-490231
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-490231URI
https://doi.org/10.1530/joe-13-0189DOI

Kompletterande språkuppgifter

Språk:engelska
Sammanfattning på:engelska

Ingår i deldatabas

SwePubSwePub

Klassifikation

Ämneskategori:ref swepub-contenttype
Ämneskategori:art swepub-publicationtype

Anmärkningar

Glucocorticoids (GCs) are stress hormones primarily responsible for mobilizing glucose to the circulation. Due to this effect, insulin resistance and glucose intolerance are concerns in patients with endogenous overproduction of GCs and in patients prescribed GC-based therapy. In addition, hypercortisolemic conditions share many characteristics with the metabolic syndrome. This study reports on a thorough characterization, in terms of glucose control and lipid handling, of a mouse model where corticosterone is given via the drinking water. C57BL/6J mice were treated with corticosterone (100 or 25 μg/ml) or vehicle in their drinking water for 5 weeks after which they were subjected to insulin or glucose tolerance tests. GC-treated mice displayed increased food intake, body weight gain, and central fat deposit accumulations. In addition, the GC treatment led to dyslipidemia as well as accumulation of ectopic fat in the liver and skeletal muscle, having a substantial negative effect on insulin sensitivity. Also glucose intolerance and hypertension, both part of the metabolic syndrome, were evident in the GC-treated mice. However, the observed effects of corticosterone were reversed after drug removal. Furthermore, this study reveals insights into β-cell adaptation to the GC-induced insulin resistance. Increased pancreatic islet volume due to cell proliferation, increased insulin secretion capacity, and increased islet chaperone expression were found in GC-treated animals. This model mimics the human metabolic syndrome. It could be a valuable model for studying the complex mechanisms behind the development of the metabolic syndrome and type 2 diabetes, as well as the multifaceted relations between GC excess and disease.

Biuppslag (personer, institutioner, konferenser, titlar ...)

Franzén, StephanieUppsala universitet,Anestesiologi och intensivvård(Swepub:uu)stefr631 (författare)
Rosengren, Victoria (författare)
Wolbert, Petra (författare)
Sjöholm, Åke (författare)
Ortsäter, Henrik (författare)
Uppsala universitetAnestesiologi och intensivvård (creator_code:org_t)

Sammanhörande titlar

Ingår i:Journal of Endocrinology: Bioscientifica219:3, s. 231-2410022-07951479-6805

Internetlänk

Hitta via bibliotek

Journal of Endocrinology (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Fransson, Liselo ...; Franzén, Stephan ...; Rosengren, Victo ...; Wolbert, Petra; Sjöholm, Åke; Ortsäter, Henrik

Artiklar i publikationen: Journal of Endoc ...

Av lärosätet: Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se